What Happened?
Boston, MA-based Quellis-Biosciences Appointed Jonathan Violin as Chief Executive Officer
About the Company
Quellis was founded to deliver best-in-class therapies to patients suffering serious rare diseases – and underserved by current treatment options. The Company is based in Boston, and is led by partners from the biotech incubator Viridian LLC in collaboration with team at biotech accelerator Xontogeny LLC, and with funding from the Perceptive Xontogeny Venture Fund. The Quellis team has deep experience in mAb discovery and development, company creation, and private and public biotech investment. Our shared goal is to create meaningful medicines for every disease we target.
About the Person
Jonathan Violin is Chief Executive Officer at Quellis Biosciences. Previously, Jonathan held various senior HR leadership roles in the industry.
Info Source
News
Short Profile